drugset / Trial / NCT00168402

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

NCT00168402 ↗

Phase 3 Completed 193 enrolled Allergan
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a three-year study in subjects with axillary hyperhidrosis involving injection of Botulinum Toxin Type A into the axilla to reduce sweating.

Timeline

Start
2002-02
Primary completion
2005-10
Completion
2005-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic — Other